Trial intelligence / Profile preview

Skin Irritancy of Vovilup Spray vs Iodex Ultragel

NCT02400320Phase 4Withdrawn

Sponsor
GSK
Start
Mar 2016
Primary completion
Jun 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of Vovilup in pain, sponsored by GSK. Planned start Mar 2016; status: withdrawn.

02

Drugs

Vovilup
03

Conditions

pain

Beyond the preview

Go deeper on NCT02400320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02400320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call